BullFrog AI Holdings, Inc. (BFRG): Cash & Equivalents
$2.18M
As of 2025-12-31
$6.92M
As of 2026-06-30
+235.8%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.18M | -59.8% | 2026-03-19, Balance as of period end |
| 2024-12-31 | $5.44M | +107.1% | 2026-03-19, Balance as of period end |
| 2023-12-31 | $2.62M | n/m | 2025-03-14, Balance as of period end |
| 2022-12-31 | $57.7K | n/a | 2024-03-29, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.18M | -59.8% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $3.06M | -16.8% |
| iBio, Inc. (IBIO) | 2026-06-30 | $56.40M | +557.1% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $48.00M | -34.2% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $15.04M | +156.7% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $15.96M | -1.6% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $4.75M | +21.6% |
| Clene Inc. (CLNN) | 2025-12-31 | $5.19M | -57.3% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $44.27M | -32.7% |
Compare BFRG, SER, IBIO, ATNM side by side · Screen every company in Pharmaceutical Preparations ↗